Neuropace, inc.NPCE.US Overview

US StockHealthcare

(No presentation for NPCE)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

NPCE Overall Performance

NPCE AI Analysis & Strategy

NPCE Recent Performance

2.86%

Neuropace, inc.

0.81%

Avg of Sector

-1.14%

S&P500

NPCE PowerScanner

NPCE Key Information

NPCE Valuation Metrics

NPCE Earnings Table

NPCE Profile

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.